These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention. Talbert RL J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609 [TBL] [Abstract][Full Text] [Related]
23. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence. Antza C; Stabouli S; Kotsis V Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487 [TBL] [Abstract][Full Text] [Related]
24. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW; JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064 [TBL] [Abstract][Full Text] [Related]
25. Do intensive blood pressure lowering and low-dose ASA help our hypertensive patients? Evans MF Can Fam Physician; 1998 Dec; 44():2655-7. PubMed ID: 9870118 [No Abstract] [Full Text] [Related]
29. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients. Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331 [TBL] [Abstract][Full Text] [Related]
30. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study. Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826 [TBL] [Abstract][Full Text] [Related]
31. [Control of blood pressure in prevention of hypertensive end-organ damage]. Kido M; Ando K; Fujita T Nihon Rinsho; 2004 Mar; 62 Suppl 3():389-93. PubMed ID: 15171405 [No Abstract] [Full Text] [Related]
32. Should we prefer different drugs to treat hypertension in older and younger adults? Practical implications of clinical trials: European perspective. Verdecchia P; Gentile G; Angeli F; Reboldi G Pol Arch Med Wewn; 2008 Sep; 118(9):513-6. PubMed ID: 18846987 [TBL] [Abstract][Full Text] [Related]